Your browser doesn't support javascript.
loading
First report of CART treatment in AL amyloidosis and relapsed/refractory multiple myeloma.
Oliver-Caldes, Aina; Jiménez, Raquel; Español-Rego, Marta; Cibeira, Maria Teresa; Ortiz-Maldonado, Valentín; Quintana, Luis F; Castillo, Paola; Guijarro, Francesca; Tovar, Natalia; Montoro, Mercedes; Benitez-Ribas, Daniel; Bataller, Alex; González-Navarro, E Azucena; Cid, Joan; Lozano, Miquel; Perez-Amill, Lorena; Martin-Antonio, Beatriz; Mena, Mari-Pau; Moreno, David F; Rodríguez-Lobato, Luis Gerardo; Campistol, Josep Maria; Calvo, Gonzalo; Bladé, Joan; Rosiñol, Laura; Juan, Manel; Pascal, Mariona; Urbano-Ispizua, Alvaro; Fernández de Larrea, Carlos.
Afiliação
  • Oliver-Caldes A; Hematology Department, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Hospital Clinic de Barcelona, Barcelona, Spain.
  • Jiménez R; Amyloidosis and Multiple Myeloma Unit, Hospital Clinic de Barcelona, Barcelona, Spain.
  • Español-Rego M; Hematology Department, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Hospital Clinic de Barcelona, Barcelona, Spain.
  • Cibeira MT; Amyloidosis and Multiple Myeloma Unit, Hospital Clinic de Barcelona, Barcelona, Spain.
  • Ortiz-Maldonado V; Clinical Trial Unit, Hospital Clinic de Barcelona, Barcelona, Spain.
  • Quintana LF; Immunology Department, Hospital Clinic de Barcelona, Barcelona, Spain.
  • Castillo P; Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Hospital Clinic de Barcelona, Barcelona, Spain.
  • Guijarro F; Hematology Department, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Hospital Clinic de Barcelona, Barcelona, Spain.
  • Tovar N; Amyloidosis and Multiple Myeloma Unit, Hospital Clinic de Barcelona, Barcelona, Spain.
  • Montoro M; Hematology Department, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Hospital Clinic de Barcelona, Barcelona, Spain.
  • Benitez-Ribas D; Amyloidosis and Multiple Myeloma Unit, Hospital Clinic de Barcelona, Barcelona, Spain.
  • Bataller A; Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Hospital Clinic de Barcelona, Barcelona, Spain.
  • González-Navarro EA; Glomerular Disease Unit (CSUR), Nephrology Department, Hospital Clinic de Barcelona, Barcelona, Spain.
  • Cid J; Amyloidosis and Multiple Myeloma Unit, Hospital Clinic de Barcelona, Barcelona, Spain.
  • Lozano M; Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Hospital Clinic de Barcelona, Barcelona, Spain.
  • Perez-Amill L; Pathology Department, Hospital Clinic de Barcelona, Barcelona, Spain.
  • Martin-Antonio B; Hematopathology Unit, Hospital Clinic de Barcelona, Barcelona, Spain.
  • Mena MP; Hematology Department, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Hospital Clinic de Barcelona, Barcelona, Spain.
  • Moreno DF; Amyloidosis and Multiple Myeloma Unit, Hospital Clinic de Barcelona, Barcelona, Spain.
  • Rodríguez-Lobato LG; Clinical Trial Unit, Hospital Clinic de Barcelona, Barcelona, Spain.
  • Campistol JM; Hematology Department, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Hospital Clinic de Barcelona, Barcelona, Spain.
  • Calvo G; Immunology Department, Hospital Clinic de Barcelona, Barcelona, Spain.
  • Bladé J; Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Hospital Clinic de Barcelona, Barcelona, Spain.
  • Rosiñol L; Hematology Department, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Hospital Clinic de Barcelona, Barcelona, Spain.
  • Juan M; Immunology Department, Hospital Clinic de Barcelona, Barcelona, Spain.
  • Pascal M; Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Hospital Clinic de Barcelona, Barcelona, Spain.
  • Urbano-Ispizua A; Apheresis Unit, Hospital Clinic de Barcelona, Barcelona, Spain.
  • Fernández de Larrea C; Apheresis Unit, Hospital Clinic de Barcelona, Barcelona, Spain.
J Immunother Cancer ; 9(12)2021 12.
Article em En | MEDLINE | ID: mdl-34876408

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Imunoterapia Adotiva / Resistencia a Medicamentos Antineoplásicos / Amiloidose de Cadeia Leve de Imunoglobulina / Mieloma Múltiplo / Recidiva Local de Neoplasia Limite: Female / Humans / Middle aged Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Imunoterapia Adotiva / Resistencia a Medicamentos Antineoplásicos / Amiloidose de Cadeia Leve de Imunoglobulina / Mieloma Múltiplo / Recidiva Local de Neoplasia Limite: Female / Humans / Middle aged Idioma: En Ano de publicação: 2021 Tipo de documento: Article